Compartilhar
Informação da revista
Vol. 43. Núm. S1.
Páginas S137 (Outubro 2021)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Vol. 43. Núm. S1.
Páginas S137 (Outubro 2021)
Open Access
METABOLIC PROFILE OF BONE MARROW PLASMA IN MYELOPROLIFERATIVE NEOPLASMS
Visitas
1120
MC Cacemiroa, JG Cominala, FC Almeidaa, MC Oliveirab, CA Sorgic, LL Figueiredo-Pontesd, LH Facciolia, LG Gardinassie, FA Castroa
a Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP), Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil
b Centro de Terapia Celular, Fundação Hemocentro de Ribeirão Preto (FUNDHERP), Ribeirão Preto, SP, Brazil
c Departamento de Quimica, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto (FFCLRP), Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil
d Departamento de Imagens Medicas, Hematologia e Oncologia, Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil
e Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás (UFG), Goiânia, GO, Brazil
Este item recebeu

Under a Creative Commons license
Informação do artigo
Suplemento especial
Este artigo faz parte de:
Vol. 43. Núm S1
Mais dados
Introduction

Bioactive lipids have been related to several biological functions such as immune system regulation, angiogenesis, cell survival, and proliferation. They are categorized into eight families: fatty acyls (fatty acids and eicosanoids), glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, polyketides, and saccharolipids. The deregulation of bioactive lipids secretion and production has been shown to contribute to cancer pathogenesis.

Aim

To quantify eicosanoids levels in bone marrow plasma from myeloproliferative neoplasms patients and healthy subjects.

Subject and methods

Nine polycythemia vera (PV), 8 primary myelofibrosis (PMF) and 8 essential thrombocythemia (ET) patients at diagnosis and 8 healthy subjects (CT) were investigated. CT group was composed by 4 males and 4 females with a median age of 43 years (y). The PV group was composed by 5 males and 4 females, median age of 61 y; ET group was composed of 1 male and 7 females, median age of 58, and, PMF group was composed by 3 female and 5 males, median age of 68 y. Bone marrow plasma samples were analyzed by high performance liquid chromatography followed by mass spectroscopy. The metabolomics analyzes were performed by using the mass spectral data acquired with negative electrospray ionization and the full scan of the mass/charge ratio (m/z) from 100 to 1500.

Results

The results showed that 7346 bioactive lipids compounds were detected in bone marrow plasma from patients and controls. Among all the analyzed compounds we found that 129 of them overlap between all comparisons, as 241 are specific to PMF, 873 to PV and 374 to ET. The predictive analysis of activity of metabolic pathways showed that for PMF and ET, the main deregulated metabolic pathways are bile acid biosynthesis and fatty acid oxidation, while for in PV the deregulated pathways are: arginine and proline metabolism, biopterin metabolism, glutamate metabolism, Glycosphingolipid biosynthesis, Glyoxylate and Dicarboxylate Metabolism, Pyruvate Metabolism, Phytanic acid peroxisomal oxidation, Sphingolipid metabolism, Vitamin E metabolism, Polyunsaturated fatty acid biosynthesis and Xenobiotics metabolism.

Discussion

These data suggest that the bone marrow microenvironment from MPN patients is deregulated, culminating in the deregulation of bioactive lipids and several metabolic pathways.

Conclusion

Each disease category presents a metabolic signature, which could be used as biomarker for diagnosis and prognosis and therapeutic target.

Funding

CAPES, CNPq and FAPESP (2018-01756-5; 2018/18714-7).

Keywords

Metabolomic analysis; Polycythemia vera; Essential thrombocythemia; Primary myelofibrosis.

O texto completo está disponível em PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Opções de artigo
Ferramentas